This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: j.jacc.2007.02.046v1 49/22/2145    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (44) Citing Articles via Google Scholar Google Scholar Articles by Brilakis, E. S. Articles by Berger, P. B. Search for Related Content PubMed PubMed Citation Articles by Brilakis, E. S. Articles by Berger, P. B.

STATE-OF-THE-ART PAPER

Perioperative Management of Patients With Coronary Stents

Emmanouil S. Brilakis, MD, PhD, FACC^_*,_*, Subhash Banerjee, MD, FACC^_* and Peter B. Berger, MD, FACC^,1

^_* Division of Cardiovascular Diseases, University of Texas Southwestern Medical Center, and Dallas VA Medical Center, Dallas, Texas
Geisinger Clinic, Danville, Pennsylvania.

Manuscript received December 12, 2006; revised manuscript received February 21, 2007, accepted February 27, 2007.

^_* Reprint requests and correspondence: Dr. Emmanouil S. Brilakis, Dallas VA Medical Center (111A), 4500 South Lancaster Road, Dallas, Texas 75216. (Email: emmanouil.brilakis{at}utsouthwestern.edu).

Perioperative coronary stent thrombosis is a catastrophic complication that can occur in patients receiving both bare-metal and drug-eluting stents. Noncardiac surgery appears to increase the risk that recently-placed stents thrombose, especially when surgery is performed early after stenting, and particularly if dual antiplatelet therapy is discontinued. We reviewed the existing data about the frequency of stent thrombosis after noncardiac surgery and explored the impact of delay from surgery and discontinuation of antiplatelet therapy. We also reviewed the data about the impact of preoperative revascularization in patients known to require noncardiac surgery. Based on these published data, we offer recommendations that can be used to guide the treatment of patients who require noncardiac surgery after having received a stent.

Abbreviations and Acronyms   AMI = acute myocardial infarction   BMS = bare-metal stent(s)   CI = confidence interval   DES = drug-eluting stent(s)   PCI = percutaneous coronary intervention   PES = paclitaxel-eluting stent(s)   SES = sirolimus-eluting stent(s)

This article has been cited by other articles:

				D. J. Angiolillo, M. S. Firstenberg, M. J. Price, P. E. Tummala, M. Hutyra, I. J. Welsby, M. D. Voeltz, H. Chandna, C. Ramaiah, M. Brtko, et al. Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery: A Randomized Controlled Trial JAMA, January 18, 2012; 307(3): 265 - 274. [Abstract] [Full Text] [PDF]

				D. P. Ceppa, I. J. Welsby, T. Y. Wang, M. W. Onaitis, B. C. Tong, D. H. Harpole, T. A. D'Amico, and M. F. Berry Perioperative Management of Patients on Clopidogrel (Plavix) Undergoing Major Lung Resection Ann. Thorac. Surg., December 1, 2011; 92(6): 1971 - 1976. [Abstract] [Full Text] [PDF]

				M. A. Gaglia Jr and R. Waksman Systematic review of thienopyridine discontinuation and its impact upon clinical outcomes Eur. Heart J., October 1, 2011; 32(19): 2358 - 2364. [Abstract] [Full Text] [PDF]

				N. S. Weitzel, S. B. Edelstein, J. C. Cleveland Jr, and C. B. Cornelissen Drug-Eluting Stents in the Perioperative Period: What Are the Key Aspects in Management? Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2011; 15(1-2): 44 - 48. [PDF]

				T.-H. Chen and R. Matyal The Management of Antiplatelet Therapy in Patients With Coronary Stents Undergoing Noncardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2010; 14(4): 256 - 273. [Abstract] [PDF]

				M. P. DeVile and P. Foex Antiplatelet drugs, coronary stents, and non-cardiac surgery CEACCP, December 1, 2010; 10(6): 187 - 191. [Full Text] [PDF]

				P. B. Berger, N. S. Kleiman, M. J. Pencina, W.-H. Hsieh, S. R. Steinhubl, A. Jeremias, A. Sonel, K. Browne, G. Barseness, D. J. Cohen, et al. Frequency of Major Noncardiac Surgery and Subsequent Adverse Events in the Year After Drug-Eluting Stent Placement: Results From the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry J. Am. Coll. Cardiol. Intv., September 1, 2010; 3(9): 920 - 927. [Abstract] [Full Text] [PDF]

				H. Mollmann, H. M. Nef, and C. W. Hamm Antiplatelet therapy during surgery Heart, June 1, 2010; 96(12): 986 - 991. [Full Text] [PDF]

				S. Savonitto, M. D'Urbano, M. Caracciolo, F. Barlocco, G. Mariani, M. Nichelatti, S. Klugmann, and S. De Servi Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel Br. J. Anaesth., March 1, 2010; 104(3): 285 - 291. [Abstract] [Full Text] [PDF]

				A. O. Abualsaud and M. J. Eisenberg Perioperative Management of Patients With Drug-Eluting Stents J. Am. Coll. Cardiol. Intv., February 1, 2010; 3(2): 131 - 142. [Abstract] [Full Text] [PDF]

				M Cleanthis and M. Flather The dangers of stopping clopidogrel perioperatively: a cardiologist's perspective Clin Risk, May 1, 2009; 15(3): 106 - 108. [Full Text] [PDF]

				S.-M. Park, D.-H. Kim, Y.-T. Kwak, and I.-S. Sohn Triple Aortic Root Injury Ann. Thorac. Surg., February 1, 2009; 87(2): 621 - 623. [Abstract] [Full Text] [PDF]

				J. M. O'Riordan, R. J. Margey, G. Blake, and P. R. O'Connell Antiplatelet Agents in the Perioperative Period Arch Surg, January 1, 2009; 144(1): 69 - 76. [Abstract] [Full Text] [PDF]

				S. Hoeks and D. Poldermans CHAPTER 34 Non-cardiac Surgery in Cardiac Patients ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]

				K. Danielyan, K. Ganguly, B.-S. Ding, D. Atochin, S. Zaitsev, J.-C. Murciano, P. L. Huang, S. E. Kasner, D. B. Cines, and V. R. Muzykantov Cerebrovascular Thromboprophylaxis in Mice by Erythrocyte-Coupled Tissue-Type Plasminogen Activator Circulation, September 30, 2008; 118(14): 1442 - 1449. [Abstract] [Full Text] [PDF]

				L. T. Newsome, R. S. Weller, J. C. Gerancher, M. A. Kutcher, and R. L. Royster Coronary Artery Stents: II. Perioperative Considerations and Management Anesth. Analg., August 1, 2008; 107(2): 570 - 590. [Abstract] [Full Text] [PDF]

				S. R. Dixon, C. L. Grines, and W. W. O'Neill The Year in Interventional Cardiology J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2355 - 2369. [Full Text] [PDF]

				J. D. Douketis, P. B. Berger, A. S. Dunn, A. K. Jaffer, A. C. Spyropoulos, R. C. Becker, and J. Ansell The Perioperative Management of Antithrombotic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 299S - 339S. [Abstract] [Full Text] [PDF]

				D. Poldermans, S. E. Hoeks, and H. H. Feringa Pre-Operative Risk Assessment and Risk Reduction Before Surgery J. Am. Coll. Cardiol., May 20, 2008; 51(20): 1913 - 1924. [Abstract] [Full Text] [PDF]

				E. Siniorakis, G. Kirvassilis, and N. Exadactylos Intraoperative myocardial infarction in non-cardiac surgery: is a universal definition feasible? Eur. Heart J., February 2, 2008; 29(4): 567 - 567. [Full Text] [PDF]